Relay Therapeutics Inc (RLAY) returns
Relay Therapeutics returns over 5 years
$1,000 invested in Relay Therapeutics five years ago was worth $551.88 at the close on October 30, 2026, with dividends reinvested: an average return of -11.2% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +1.7% | — | $1,017 | -0.9% |
| 3 months | -5.7% | — | $943.44 | +2.1% |
| Year to date | +116.9% | — | $2,169 | +11.7% |
| 1 year | +150.0% | — | $2,500 | +12.4% |
| 3 years | +194.5% | +43.3% | $2,945 | +88.5% |
| 5 years | -44.8% | -11.2% | $551.88 | +76.0% |
Relay Therapeutics return by calendar year
| Year | RLAY | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +116.9% | +11.7% | +105.2% |
| 2025 | +105.3% | +17.7% | +87.6% |
| 2024 | -62.6% | +24.9% | -87.5% |
| 2023 | -26.3% | +26.2% | -52.5% |
| 2022 | -51.4% | -18.2% | -33.2% |
| 2021 | -26.1% | +28.7% | -54.9% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: RLAY financials
No forecast, no recommendation. This page describes Relay Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.